IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
162 hedge funds and large institutions have $1.36B invested in IVERIC bio, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 61 increasing their positions, 46 reducing their positions, and 22 closing their positions.
269% more call options, than puts
Call options by funds: $15.5M | Put options by funds: $4.21M
45% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 22
33% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 46
7% more funds holding
Funds holding: 152 → 162 (+10)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
45% less capital invested
Capital invested by funds: $2.47B → $1.36B (-$1.11B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$54.7M |
| 2 |
SPC
Slate Path Capital
New York
|
+$21.9M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$21.1M |
| 4 |
State Street
Boston,
Massachusetts
|
+$18.9M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$12.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$74.3M |
| 2 |
Millennium Management
New York
|
-$42.5M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$19.9M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$5.95M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5.87M |
ISEE Hedge Fund Activity: Q1 2016 in Review
162 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q1 2016, worth a combined $1.36B — down 45% from $2.47B a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new ISEE positions and 22 closed out — a net gain of 10 holders — while 61 added to existing stakes and 46 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $54.7M. The largest seller was Fidelity Investments, cutting an estimated $74.3M.
- 162 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q1 2016, up from 152 in Q4 2015.
- Funds reported $1.36B of IVERIC bio, Inc. Common Stock stock for Q1 2016, down 45% quarter-over-quarter.
- 32 funds opened new IVERIC bio, Inc. Common Stock positions in Q1 2016 and 22 closed out, a net change of +10 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q1 2016 was Morgan Stanley, an estimated $54.7M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q1 2016 was Fidelity Investments, an estimated $74.3M sold.
Based on aggregated 13F filings for Q1 2016.